[HTML][HTML] Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy

EJ Song, KH Jeong, YA Yang, JH Lim… - Kidney research and …, 2018 - ncbi.nlm.nih.gov
Background Phospholipase A2 receptor (PLA2R) has been identified as a major
autoantigen in primary membranous nephropathy (MN). We evaluated the association …

Phospholipase A2 receptor antibodies and clinical prognosis in patients with idiopathic membranous nephropathy: an updated systematic review and meta-analysis

J Zhang, Z Fan, P Wang, AH Zhang - Kidney and Blood Pressure …, 2023 - karger.com
Background: Idiopathic membranous nephropathy (IMN) is the most common form of primary
nephrotic syndrome in adults. Antibodies against the M-type phospholipase A2 receptor …

The genetic and environmental factors of primary membranous nephropathy: an overview from China

X Zhang, Z Cui, M Zhao - Kidney Diseases, 2018 - karger.com
Background: Primary membranous nephropathy (pMN) is the most common cause of
nephrotic syndrome in adults. The discovery of the 2 autoantigens, M-type phospholipase …

Antibodies against M-type phospholipase A2 receptor may predict treatment response and outcome in membranous nephropathy

Z Qu, M Zhang, Z Cui, J Wang, M Wang… - American Journal of …, 2018 - karger.com
Background: Anti-phospholipase A2 receptor (PLA2R) antibodies are specific to the
diagnosis of primary membranous nephropathy (pMN). The prevalence of positive …

Advances in pathogenesis of idiopathic membranous nephropathy

Z Xu, L Chen, H Xiang, C Zhang, J Xiong - Kidney Diseases, 2020 - karger.com
Abstract Background: Membranous nephropathy (MN), a major cause of nephrotic
syndrome, has attracted people's attention in recent years for its growing prevalence. It is the …

[HTML][HTML] The prognostic value of phospholipase A2 receptor autoantibodies on spontaneous remission for patients with idiopathic membranous nephropathy: a meta …

W Wu, J Shang, C Tao, S Wang, X Hu, S Zhang… - Medicine, 2018 - journals.lww.com
Background: The presence of antibodies against phospholipase A2 receptor (PLA2R-Abs)
in serum at diagnosis is reported to be related to the rate of spontaneous remission in …

[HTML][HTML] Development of a standardized chemiluminescence immunoassay for the detection of autoantibodies against human M-type phospholipase A2 receptor in …

C Dähnrich, S Saschenbrecker, I Gunnarsson… - Kidney International …, 2020 - Elsevier
Introduction Autoantibodies against the M-type phospholipase A2 receptor (PLA2R) are
important markers in the diagnosis and monitoring of primary membranous nephropathy …

Improvement of membranous nephropathy by inhibition of miR‐193a to affect podocytosis via targeting WT1

J Li, Y Chen, L Shen, Y Deng - Journal of cellular biochemistry, 2019 - Wiley Online Library
The objective of this paper was to explore the role and molecular mechanism of miR‐193a
in membranous nephropathy (MN). Experimental rats and podocytes were randomly divided …

Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a …

D Dong, T Fan, Y Wang, L Zhang, L Song, L Zhang - BMC nephrology, 2019 - Springer
Objective To investigate the correlation of M-type phospholipase A2 receptor (PLA2R)
expression and serum anti-PLA2R antibody with the clinical parameters and prognosis of …

Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings

B Kaya, S Paydas, M Balal… - … Journal of Clinical …, 2021 - Wiley Online Library
Background Membranous nephropathy (MN) is the most common cause of nephrotic
syndrome in nondiabetic adults. M‐type phospholipase A2 receptor (PLA2R) …